Becton Dickinson & Co (BDX)
238.07
+1.49
(+0.63%)
USD |
NYSE |
May 07, 15:26
Becton Dickinson Enterprise Value: 83.21B for May 6, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 06, 2024 | 83.21B |
| May 03, 2024 | 82.66B |
| May 02, 2024 | 84.30B |
| May 01, 2024 | 82.38B |
| April 30, 2024 | 82.64B |
| April 29, 2024 | 82.30B |
| April 26, 2024 | 81.76B |
| April 25, 2024 | 81.45B |
| April 24, 2024 | 82.41B |
| April 23, 2024 | 82.57B |
| April 22, 2024 | 82.43B |
| April 19, 2024 | 82.50B |
| April 18, 2024 | 82.22B |
| April 17, 2024 | 81.95B |
| April 16, 2024 | 81.60B |
| April 15, 2024 | 82.67B |
| April 12, 2024 | 82.80B |
| April 11, 2024 | 84.37B |
| April 10, 2024 | 84.48B |
| April 09, 2024 | 85.88B |
| April 08, 2024 | 84.69B |
| April 05, 2024 | 85.98B |
| April 04, 2024 | 85.08B |
| April 03, 2024 | 85.24B |
| April 02, 2024 | 84.49B |
| Date | Value |
|---|---|
| April 01, 2024 | 85.37B |
| March 31, 2024 | 86.35B |
| March 28, 2024 | 86.42B |
| March 27, 2024 | 86.15B |
| March 26, 2024 | 84.81B |
| March 25, 2024 | 84.75B |
| March 22, 2024 | 86.07B |
| March 21, 2024 | 84.73B |
| March 20, 2024 | 83.65B |
| March 19, 2024 | 84.33B |
| March 18, 2024 | 83.61B |
| March 15, 2024 | 83.31B |
| March 14, 2024 | 83.45B |
| March 13, 2024 | 83.92B |
| March 12, 2024 | 83.63B |
| March 11, 2024 | 84.12B |
| March 08, 2024 | 84.24B |
| March 07, 2024 | 83.58B |
| March 06, 2024 | 82.99B |
| March 05, 2024 | 82.37B |
| March 04, 2024 | 83.01B |
| March 01, 2024 | 82.91B |
| February 29, 2024 | 82.98B |
| February 28, 2024 | 84.02B |
| February 27, 2024 | 84.62B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
73.23B
Minimum
Mar 23 2020
98.12B
Maximum
Jul 27 2023
86.86B
Average
86.63B
Median
Enterprise Value Benchmarks
| AngioDynamics Inc | 169.89M |
| West Pharmaceutical Services Inc | 26.30B |
| Intuitive Surgical Inc | 131.15B |
| Merit Medical Systems Inc | 4.838B |
| Insulet Corp | 13.05B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 537.00M |
| Revenue (Quarterly) | 5.045B |
| Total Expenses (Quarterly) | 4.21B |
| EPS Diluted (Quarterly) | 1.85 |
| Gross Profit Margin (Quarterly) | 45.67% |
| Profit Margin (Quarterly) | 10.64% |
| Earnings Yield | 1.91% |
| Operating Earnings Yield | 3.54% |
| Normalized Earnings Yield | 2.485 |